Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.
Feature | Udi Nussinovitch M.D., Ph.D.
What is New in Cardiology? A Review of All Major Emerging Technologies for Heart Diseases

This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...

Home October 09, 2020
Home
The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.
News | Heart Valve Technology
Cardiac Dimensions Announces $17.5 Million in Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System

October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...

Home October 02, 2020
Home
Videos | Left Atrial Appendage (LAA) Occluders
VIDEO: Overview of Left Atrial Appendage (LAA) Closure Technology and New Innovations

Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal ...

Home October 02, 2020
Home
Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI
News | Heart Valve Technology
Boston Scientific Launches Acurate neo2 Transcatheter Aortic Valve System in Europe

September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in ...

Home September 29, 2020
Home
The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 
News | Wearables
VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study

September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the ...

Home September 25, 2020
Home
TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT
Feature | TCT
TCT 2020 Late-breaking Study Presentations Announced

October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular ...

Home October 15, 2020
Home
Videos | Structural Heart
VIDEO: Interventional Structural Heart Advances Are Rapidly Expanding

Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) explains structural heart innovations and new ...

Home September 16, 2020
Home
Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system. The study begins on the heels of a recent Breakthrough Device Designation issued by the FDA for the Intrepid TTVR System. The Intrepid TTVR system is an investigational device worldwide.
News | Heart Valve Technology
Medtronic Receives FDA Breakthrough Device Designation and Begins Trial for Intrepid Tricuspid Transcatheter Valve 

September 11, 2020 – Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study ...

Home September 11, 2020
Home
An example of a 80-year-old TAVR patient planning CT scan from Northwestern Medicine's Central DuPage Hospital. This was used in a heart team meeting with the TAVR staff, including a cardiac surgeon and interventional cardiologist, to determine if this patient was eligable for TAVR, the best access routes to deliver the valve, device valve size needed, and to look for any potential anatomical issues so they can be planned for. 
News | Structural Heart
Northwestern Medicine Celebrates 2000th Transcatheter Heart Valve Procedure

September 2, 2020 — Northwestern Medicine Bluhm Cardiovascular Institute physicians recently completed their 2,000th tra ...

Home September 02, 2020
Home
Researchers 3-D Print Lifelike Heart Valve Models with embedded sensor technology
News | Medical 3-D Printing
Researchers 3-D Print Lifelike Heart Valve Models

September 2, 2020 — Patient-specific organ models are being used by the University of Minnesota to better prepare for ...

Home September 02, 2020
Home
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell
Feature | Tufts Medical Center | Dave Fornell, Editor
Cardiovascular Innovation at Tufts Medical Center

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

Home August 21, 2020
Home
Boston Scientific recently introduced the newst iteration of LAA occluder device, the Watchman FLX. It uses small spikes to help better anchor the device and prevent embolization.
News | Left Atrial Appendage (LAA) Occluders
COVID-19 Boosts Demand for Left Atrial Appendage Closure Devices Market

August 21, 2020 — According to a report published by Research Dive, the rising number of patients suffering from atrial ...

Home August 21, 2020
Home
National Survey Of Heart Valve Patients Shows Importance Of Seeking Treatment Early
News | Heart Valve Technology
National Survey Of Heart Valve Patients Shows Importance Of Seeking Treatment Early

August 12, 2020 — A national survey conducted by the patient advocacy group Heart-Valve-Surgery.com with support by ...

Home August 12, 2020
Home
The Conformal Medical CLAAS device, a next-generation transcatheter left atrial appendage (LAA) closure occluder for patients with atrial fibrillation (AF). LAA occlusion allows AFib patients to go off of life-long anticoagulation therapy. #LAA #LAAC
News | Left Atrial Appendage (LAA) Occluders
Conformal Medical Secures $85 Million in Funding for Left Atrial Appendage Occluder Trial

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...

Home August 06, 2020
Home
CardioMech's transcatheter chordae tendineae repair system uses a catheter to attach an anchor on the mitral valve leaflet and then attaches it via a cord to the apex of the heart.
News | Heart Valve Technology
Transcatheter Mitral Valve Repair Startup CardioMech Raised $18.5 Million

August 5, 2020 – Minneapolis-based CardioMech AS, a medical device company developing a transfemoral, transseptally ...

Home August 05, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now